MoneyWorks4Me

ANG Lifesciences India informs about disclosure

26 Feb 2022 Evaluate

ANG Lifesciences India has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers)Regulations, 2011 for Rajesh Gupta.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1805.10
Dr. Reddys Labs. 1202.70
Cipla 1344.90
Lupin 2018.50
Zydus Lifesciences 1137.00
View more..